Benjamin Thomas Davis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proctitis | 2 | 2016 | 40 | 0.410 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2006 | 657 | 0.370 |
Why?
|
| Daptomycin | 1 | 2009 | 73 | 0.340 |
Why?
|
| Glycopeptides | 1 | 2009 | 224 | 0.320 |
Why?
|
| Rectum | 3 | 2016 | 904 | 0.300 |
Why?
|
| Meningococcal Infections | 1 | 2007 | 77 | 0.290 |
Why?
|
| Neisseria meningitidis | 1 | 2007 | 109 | 0.290 |
Why?
|
| Infectious Mononucleosis | 1 | 2007 | 131 | 0.290 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2006 | 13 | 0.280 |
Why?
|
| Syphilis | 3 | 2016 | 227 | 0.270 |
Why?
|
| Endocarditis, Bacterial | 1 | 2009 | 455 | 0.260 |
Why?
|
| Chlamydia trachomatis | 1 | 2006 | 246 | 0.240 |
Why?
|
| Arthritis, Infectious | 1 | 2007 | 367 | 0.220 |
Why?
|
| Cystitis | 1 | 2002 | 93 | 0.210 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 1035 | 0.210 |
Why?
|
| West Nile Fever | 1 | 2002 | 81 | 0.200 |
Why?
|
| BK Virus | 1 | 2002 | 129 | 0.200 |
Why?
|
| HIV-1 | 8 | 2014 | 6939 | 0.190 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 1400 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2007 | 2232 | 0.180 |
Why?
|
| Viremia | 4 | 2014 | 736 | 0.180 |
Why?
|
| HIV Infections | 10 | 2014 | 16718 | 0.150 |
Why?
|
| Colon, Sigmoid | 1 | 2016 | 120 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 2 | 2010 | 7181 | 0.100 |
Why?
|
| RNA, Viral | 5 | 2014 | 2902 | 0.100 |
Why?
|
| Babesiosis | 1 | 2012 | 92 | 0.100 |
Why?
|
| AIDS Dementia Complex | 1 | 2011 | 154 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2002 | 3461 | 0.090 |
Why?
|
| Eye Infections | 1 | 2010 | 64 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 258 | 0.090 |
Why?
|
| Lipodystrophy | 2 | 2000 | 147 | 0.090 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 353 | 0.080 |
Why?
|
| Viral Load | 4 | 2011 | 3299 | 0.080 |
Why?
|
| Eye Infections, Bacterial | 1 | 2010 | 235 | 0.080 |
Why?
|
| Serotyping | 1 | 2007 | 338 | 0.070 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 95 | 0.070 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 251 | 0.070 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1284 | 0.060 |
Why?
|
| Rectal Diseases | 1 | 2006 | 143 | 0.060 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 578 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2016 | 1130 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12959 | 0.060 |
Why?
|
| Lymphocyte Subsets | 1 | 2005 | 315 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2010 | 4479 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2303 | 0.060 |
Why?
|
| Gonorrhea | 1 | 2007 | 335 | 0.060 |
Why?
|
| Arthralgia | 1 | 2007 | 456 | 0.060 |
Why?
|
| Superinfection | 1 | 2002 | 65 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2012 | 1580 | 0.050 |
Why?
|
| Hypotension | 1 | 2007 | 884 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4420 | 0.050 |
Why?
|
| Polyomavirus Infections | 1 | 2002 | 197 | 0.050 |
Why?
|
| Sentinel Surveillance | 1 | 2002 | 281 | 0.040 |
Why?
|
| Fever | 1 | 2007 | 1616 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 452 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2014 | 1873 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2006 | 1379 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2002 | 880 | 0.040 |
Why?
|
| Virus Replication | 2 | 2005 | 2534 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2011 | 2559 | 0.040 |
Why?
|
| Colitis | 1 | 2006 | 1170 | 0.040 |
Why?
|
| Reagins | 1 | 2016 | 7 | 0.040 |
Why?
|
| Fissure in Ano | 1 | 2016 | 13 | 0.040 |
Why?
|
| Hemorrhoids | 1 | 2016 | 20 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5442 | 0.030 |
Why?
|
| HIV Antigens | 2 | 2010 | 347 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2006 | 1591 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 2133 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 4256 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2002 | 1381 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4026 | 0.030 |
Why?
|
| Lymphocyte Count | 2 | 2006 | 793 | 0.030 |
Why?
|
| Metformin | 1 | 2000 | 835 | 0.030 |
Why?
|
| Humans | 18 | 2016 | 744343 | 0.030 |
Why?
|
| Adult | 8 | 2016 | 214055 | 0.030 |
Why?
|
| Constipation | 1 | 2016 | 546 | 0.030 |
Why?
|
| Exanthema | 1 | 2016 | 501 | 0.030 |
Why?
|
| Male | 11 | 2016 | 350118 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2010 | 88 | 0.020 |
Why?
|
| Pain | 1 | 2006 | 4986 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 231 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 126 | 0.020 |
Why?
|
| Massachusetts | 1 | 2002 | 8663 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2010 | 411 | 0.020 |
Why?
|
| Remission Induction | 1 | 2014 | 2386 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 2872 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2014 | 2225 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2010 | 534 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2006 | 256 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2000 | 3864 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1415 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1588 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 2006 | 3206 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 971 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 1736 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 1352 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 2779 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3036 | 0.010 |
Why?
|
| Immunoassay | 1 | 2006 | 752 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2010 | 4011 | 0.010 |
Why?
|
| Disease Progression | 2 | 2010 | 13284 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2917 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2002 | 758 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5456 | 0.010 |
Why?
|
| Epitopes | 1 | 2007 | 2571 | 0.010 |
Why?
|
| Middle Aged | 6 | 2012 | 213383 | 0.010 |
Why?
|
| Female | 6 | 2012 | 380194 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6933 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 6473 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 2958 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 430 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2000 | 415 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2002 | 986 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 57776 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12951 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 1654 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2000 | 6256 | 0.010 |
Why?
|
| Insulin | 2 | 2000 | 6580 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13408 | 0.010 |
Why?
|
| Phylogeny | 1 | 2002 | 2803 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 15165 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 8340 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 7149 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2000 | 1814 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9313 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4386 | 0.010 |
Why?
|
| Cognition | 1 | 2011 | 6770 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 56430 | 0.010 |
Why?
|
| Comorbidity | 1 | 2006 | 10388 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12261 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15519 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13815 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11483 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 163280 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39050 | 0.010 |
Why?
|
| Lipids | 1 | 2000 | 3305 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40075 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 10180 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 40561 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2005 | 21746 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2000 | 8324 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12026 | 0.000 |
Why?
|
| Adolescent | 2 | 2007 | 85781 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 25043 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2007 | 41006 | 0.000 |
Why?
|
| Brain | 1 | 2011 | 26385 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63114 | 0.000 |
Why?
|
| Child | 1 | 2007 | 77709 | 0.000 |
Why?
|
| Risk Factors | 1 | 2000 | 72290 | 0.000 |
Why?
|